Regorafenib versus cabozantinb as second-line treatment after sorafenib for unresectable hepatocellular carcinoma: matching-adjusted indirect comparison analysis
Titel:
Regorafenib versus cabozantinb as second-line treatment after sorafenib for unresectable hepatocellular carcinoma: matching-adjusted indirect comparison analysis
Auteur:
Casadei-Gardini, Andrea Rimassa, Lorenza Rimini, Margherita Yoo, Changhoon Ryoo, Baek-Yeol Lonardi, Sara Masi, Gianluca Kim, Hyung-Don Vivaldi, Caterina Ryu, Min-Hee Rizzato, Mario Domenico Salani, Francesca Bang, Yeonghak Pellino, Antonio Catanese, Silvia Burgio, Valentina Cascinu, Stefano Cucchetti, Alessandro